Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biosurveillance

    Another MERS Case in U.S., Healthcare Workers Possibly Infected

    By Global Biodefense StaffMay 13, 2014
    MERS-CoV Coronavirus
    Share
    Facebook LinkedIn Reddit Email

    On May 11, 2014, a second U.S. imported case of Middle East Respiratory Syndrome (MERS) was confirmed in a traveler who came to the U.S. from Saudi Arabia. The patient is currently hospitalized and doing well.

    According to reports from Reuters, two health workers at the Dr. P. Phillips Hospital in Orlando, Florida who were exposed to the patient have now begun showing symptoms, and one of the two healthcare workers has been hospitalized. The second is in isolation at home, resting.

    MERS Coronavirus Case at Dr. P. Phillips Hospital

    Officials at the hospital say the workers were exposed to the patient in the emergency department prior to isolation of the man for suspected MERS.

    “We are taking every precaution, but we believe the risk of transmission from this patient is very low since his symptoms were mild and he was not coughing when he arrived at the hospital,” stated Antonio Crespo, MD, infectious disease specialist at Dr. Phillips Hospital in Orlando, via a press release from the Florida Department of Health (FDH).

    CDC and other public health partners continue to investigate and respond to the changing situation to prevent the spread of MERS-CoV in the U.S. These two cases of MERS imported to the U.S. represent a very low risk to the general public in this country.

    Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a virus that is new to humans and was first reported in Saudi Arabia in 2012. So far, including this U.S. importation, there have been 538 confirmed cases of MERS in 14 countries. Most of these people developed severe acute respiratory illness, with fever, cough, and shortness of breath; 145 people have died.

    Coronavirus Emerging Threats MERS-CoV
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleStudy Validates Air Sampling Techniques to Fight Bioterrorism
    Next Article Penn Develops Scalable Bio-Chemical Nanosensors

    Related Stories

    Valley Fever: An Invisible Killer Expands Its Range in the American West

    November 17, 2023

    Pandemic Flu Has Many Potential Pathways

    October 19, 2023

    USDA APHIS Announces Partnership to Improve Early Detection of Emerging Animal Diseases

    October 17, 2023

    The Basics on the Nipah Virus Outbreak in India

    September 19, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Dec 5
    10:45 am - 3:00 pm EST

    Meeting the Moment: Biodefense Policy, Procurement, and Public Health

    Dec 6
    Virtual Event Virtual Event
    6:00 am - 7:00 am EST

    AMR One Health Priority Research Agenda: Transmission

    Mar 12
    Virtual Event Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.